• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • LASIK
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

ODs must raise awareness about glaucoma

Publication
Article
Optometry Times JournalFebruary digital edition 2020
Volume 12
Issue 2

an elderly woman rests her face with glasses on hand
Dr. Casella headshot

The number of Americans living with glaucoma is projected to increase to more than 4 million in 2030 and more than 6 million by 2060. 

I hope everyone had a good and productive Glaucoma Awareness Month. It’s in January, just in case you needed a reminder for when to wear your green ribbon on the lapel of your lab coat.

Glaucoma Awareness Month is great to promote more public and policy awareness of the great silent blinder that is glaucoma, but, as with my post-Christmas mood, I am making an effort to keep the spirit of glaucoma awareness with me all year. Indeed, I am going to do my best to include this task as part of my obligation to inform and protect the public.

Related: Know what common glaucoma mistakes to avoid

As part of my new-found vigor with respect to saving vision one IOP measurement at a time, I recently read over what the National Eye Institute has to say with respect to glaucoma.1 In optometry school and residency, I learned that about one in every 100 Americans has glaucoma. From a weather forecast standpoint, that’s not a whole lot. From a clinical standpoint, that’s a ton of people!

What’s more staggering is the fact that the number of Americans living with this disease is projected to increase to more than 4 million in 2030 and more than 6 million by 2060.

Related: SD-OCT shows schisis advancements due to sickle cell

Of course, one would surmise that this increase has to do with the aging and growing population, at least in part, but are there any other variables at play with respect to such an increase?

Over the last several years, we at Optometry Times have shared numerous advances in glaucoma care and detection, and we will continue to do so in the future. However, I am charging myself with the task with better conveying what contemporary science has to say about what, if anything, can be done to avoid glaucoma in the future.

Related: Look at more than the optic nerve head in glaucoma patients

So far, what we know about glaucoma prevention goes along with common sense: try not to treat your body like a garbage can and get some exercise-oh, and choose parents who don’t have glaucoma. Who knows what the future will hold, and, as an OD with a positive family history of glaucoma, I plan to stay informed.

For now, however, optometrists have to continue to help their communities to understand the importance of comprehensive eye examinations. This means getting out and spreading the word about this disease and what optometrists can do to help patients.

I am about to roll out a social media awareness campaign about glaucoma (and eye health in general) on behalf of my practice.

I’ll keep you posted, and I hope you do the same. Email me with your ideas: bpcasella@gmail.com.

More by Dr. Casella: Coats’ disease: A case study of a 4-year old boy

Related Videos
Shan Lin, MD, speaks on Glaucoma 360 presentation in an interview with Ophthalmology Times
Danica Marrelli, OD, FAAO, AAO Dipl, co-chair of EnVision Summit chats about geographic atrophy and glaucoma panels
Nate Lighthizer, OD, speaks on lasers in optometry at AAOpt 2023
Gleb Sukhovolskiy, OD
Justin Schweitzer, OD, FAAO, and Selina McGee, OD, FAAO, Dipl ABO, discuss their AAOpt presentation on the intersection of dry eye and glaucoma
Monique Barbour, MD
Justin Schweitzer and Nate Lighthizer discuss surgical interventions in glaucoma at AOA 2023.
© 2024 MJH Life Sciences

All rights reserved.